Description
Composition
Per 1.5ml dose
| Inactivated EHV type 1, strain 438/77 | > 107.3 | TCID50 |
| Inactivated EHV type 4, strain 405/76 | > 107.3 | TCID50 |
Excipients:
Carbopol 934P 6 mg
Disodium hydrogen phosphate dehydrate
Sodium dihydrogen phosphate dehydrate
Phosphate buffer
Characteristics
Injection fluid against equine herpes virus types 1 and 4.
Indications
For the active immunisation of horses and ponies to reduce the incidence of respiratory disease and viral shedding caused by infection with equine herpes virus types 1 and 4 (EHV-1 and EHV-4) and to reduce the incidence of abortion caused by infection with EHV-1. After completion of the primary vaccination course, the presence of antibodies has been demonstrated within 2 weeks and protection against virulent challenge has been demonstrated within 3 weeks. The duration of immunity is 6 months.